Nadzan AM - Search Results

1

Retinoic acid receptor ligands based on the 6-cyclopropyl-2,4-hexadienoic acid.

Farmer LJ, Zhi L, Jeong S, Lamph WW, Osburn DL, Croston G, Flatten KS, Heyman RA, Nadzan AM. Farmer LJ, et al. Among authors: nadzan am. Bioorg Med Chem Lett. 2003 Jan 20;13(2):261-4. doi: 10.1016/s0960-894x(02)00924-1. Bioorg Med Chem Lett. 2003. PMID: 12482435

2

Aza-retinoids as novel retinoid X receptor-specific agonists.

Farmer LJ, Marron KS, Canan Koch SS, Hwang CK, Kallel EA, Zhi L, Nadzan AM, Robertson DW, Bennani YL. Farmer LJ, et al. Among authors: nadzan am. Bioorg Med Chem Lett. 2006 May 1;16(9):2352-6. doi: 10.1016/j.bmcl.2005.12.003. Epub 2005 Dec 20. Bioorg Med Chem Lett. 2006. PMID: 16364638

3

Discovery of novel retinoic acid receptor agonists having potent antiproliferative activity in cervical cancer cells.

Zhang L, Nadzan AM, Heyman RA, Love DL, Mais DE, Croston G, Lamph WW, Boehm MF. Zhang L, et al. Among authors: nadzan am. J Med Chem. 1996 Jul 5;39(14):2659-63. doi: 10.1021/jm960285j. J Med Chem. 1996. PMID: 8709094

4

Identification of the first retinoid X, receptor homodimer antagonist.

Canan Koch SS, Dardashti LJ, Hebert JJ, White SK, Croston GE, Flatten KS, Heyman RA, Nadzan AM. Canan Koch SS, et al. Among authors: nadzan am. J Med Chem. 1996 Aug 16;39(17):3229-34. doi: 10.1021/jm960311d. J Med Chem. 1996. PMID: 8765503 No abstract available.

5

Synthesis of retinoid X receptor-specific ligands that are potent inducers of adipogenesis in 3T3-L1 cells.

Canan Koch SS, Dardashti LJ, Cesario RM, Croston GE, Boehm MF, Heyman RA, Nadzan AM. Canan Koch SS, et al. Among authors: nadzan am. J Med Chem. 1999 Feb 25;42(4):742-50. doi: 10.1021/jm980621r. J Med Chem. 1999. PMID: 10052980

6

Synthesis and Characterization of a Highly Potent and Selective Isotopically Labeled Retinoic Acid Receptor Ligand, ALRT1550.

Bennani YL, Marron KS, Mais DE, Flatten K, Nadzan AM, Boehm MF. Bennani YL, et al. Among authors: nadzan am. J Org Chem. 1998 Feb 6;63(3):543-550. doi: 10.1021/jo971409i. J Org Chem. 1998. PMID: 11672043

7

Activation of specific RXR heterodimers by an antagonist of RXR homodimers.

Lala DS, Mukherjee R, Schulman IG, Koch SS, Dardashti LJ, Nadzan AM, Croston GE, Evans RM, Heyman RA. Lala DS, et al. Among authors: nadzan am. Nature. 1996 Oct 3;383(6599):450-3. doi: 10.1038/383450a0. Nature. 1996. PMID: 8837780

8

A novel retinoic acid receptor-selective retinoid, ALRT1550, has potent antitumor activity against human oral squamous carcinoma xenografts in nude mice.

Shalinsky DR, Bischoff ED, Lamph WW, Zhang L, Boehm MF, Davies PJ, Nadzan AM, Heyman RA. Shalinsky DR, et al. Among authors: nadzan am. Cancer Res. 1997 Jan 1;57(1):162-8. Cancer Res. 1997. PMID: 8988059

9

Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.

Mukherjee R, Davies PJ, Crombie DL, Bischoff ED, Cesario RM, Jow L, Hamann LG, Boehm MF, Mondon CE, Nadzan AM, Paterniti JR Jr, Heyman RA. Mukherjee R, et al. Among authors: nadzan am. Nature. 1997 Mar 27;386(6623):407-10. doi: 10.1038/386407a0. Nature. 1997. PMID: 9121558

10

Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.

Boehm MF, Fitzgerald P, Zou A, Elgort MG, Bischoff ED, Mere L, Mais DE, Bissonnette RP, Heyman RA, Nadzan AM, Reichman M, Allegretto EA. Boehm MF, et al. Among authors: nadzan am. Chem Biol. 1999 May;6(5):265-75. doi: 10.1016/S1074-5521(99)80072-6. Chem Biol. 1999. PMID: 10322128

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page